Lupin firms up board with industry titans Jeffrey Kindler and Alfonso Zulueta

Pharma major Lupin on May 9 announced the appointment of Jeffrey Kindler and Alfonso 'Chito' Zulueta as independent directors to its board.

Kindler brings with him an experience of over four decades in the healthcare sector. He has held leadership roles at companies such as Pfizer, McDonald's Corporation, and General Electric Company. With the background of chairman and CEO of Pfizer and extensive advisory roles, Kindler's expertise spans across business, investment, and legal domains, the company said in a press statement.

"Currently serving as CEO of Centrexion Therapeutics and holding positions in various companies, including Precigen Inc and Perrigo Pharmaceuticals, his strategic acumen adds valuable insights to Lupin's board," it said. Kindler is an alumnus of Tufts University and Harvard Law School.

Zulueta, on the other hand, has spent over 30 years, during which he served as the vice-president of global marketing and president of international businesses at Eli Lilly and Company. "His vast knowledge of global pharmaceutical markets and leadership skills make him a valuable addition to Lupin's board," the company said. Zulueta serves as non-executive chairman of Interpharma Investments Limited and is involved in various startup ventures. He holds degrees in economics from De La Salle University and an MBA degree from the University of Virginia.